The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ

被引：0
|
作者：
Manabu Kakizoe
Masahiro Yao
Ukihide Tateishi
Ryogo Minamimoto
Daiki Ueno
Kazuhiro Namura
Kazuhide Makiyama
Narihiko Hayashi
Futoshi Sano
Takeshi Kishida
Kazuki Kobayashi
Sumio Noguchi
Ichiro Ikeda
Yoshiharu Ohgo
Masataka Taguri
Satoshi Morita
Tomio Inoue
Yoshinobu Kubota
Noboru Nakaigawa
机构：
[1] Yokohama City University Graduate School of Medicine,Department of Urology
[2] Yokohama City University Graduate School of Medicine,Department of Radiology
[3] Kanagawa Cancer Center,Department of Urology
[4] Yokosuka Kyosai Hospital,Department of Urology
[5] Yokohama Minami Kyosai Hospital,Department of Urology
[6] Yokohama Sakae Kyosai Hospital,Department of Urology
[7] Yokohama City University Graduate School of Medicine,Department of Biostatistics and Epidemiology
[8] Kyoto University Graduate School of Medicine,Department of Biomedical Statistics and Bioinformatics
来源：
BMC Cancer | / 14卷
关键词：
Renal cell carcinoma; Tyrosine kinase inhibitor; FDG PET/CT; Metastasis; Standardized uptake value; SUVmax; Organ;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ
    Kakizoe, Manabu
    Yao, Masahiro
    Tateishi, Ukihide
    Minamimoto, Ryogo
    Ueno, Daiki
    Namura, Kazuhiro
    Makiyama, Kazuhide
    Hayashi, Narihiko
    Sano, Futoshi
    Kishida, Takeshi
    Kobayashi, Kazuki
    Noguchi, Sumio
    Ikeda, Ichiro
    Ohgo, Yoshiharu
    Taguri, Masataka
    Morita, Satoshi
    Inoue, Tomio
    Kubota, Yoshinobu
    Nakaigawa, Noboru
    BMC CANCER, 2014, 14
  • [2] The response of metastatic lesions in renal cell carcinoma to tyrosine kinase inhibitors evaluated by F-18 FDG PET/CT
    Yaylali, O.
    Yuksel, D.
    Dogu, G. G.
    Sengoz, T.
    Yaren, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S716 - S716
  • [3] Role of 18F-FDG PET/CT in the assessment of therapy response and clinical outcome in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors or immunotherapy
    Tatar, Gamze
    Alcin, Goksel
    Samanci, Nilay Sengul
    Fenercioglu, Ozge Erol
    Beyhan, Ediz
    Cermik, Tevfik Fikret
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (06) : 701 - 709
  • [4] Sequential assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors
    Nakaigawa, N.
    Yao, M.
    Tateishi, U.
    Kobayashi, K.
    Kishida, T.
    Makiyama, K.
    Kondoh, K.
    Inoue, T.
    Kubota, Y.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S672 - S672
  • [5] Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course
    Daiki Ueno
    Masahiro Yao
    Ukihide Tateishi
    Ryogo Minamimoto
    Kazuhide Makiyama
    Narihiko Hayashi
    Futoshi Sano
    Takayuki Murakami
    Takeshi Kishida
    Takeshi Miura
    Kazuki Kobayashi
    Sumio Noguchi
    Ichiro Ikeda
    Yoshiharu Ohgo
    Tomio Inoue
    Yoshinobu Kubota
    Noboru Nakaigawa
    BMC Cancer, 12
  • [6] Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course
    Ueno, Daiki
    Yao, Masahiro
    Tateishi, Ukihide
    Minamimoto, Ryogo
    Makiyama, Kazuhide
    Hayashi, Narihiko
    Sano, Futoshi
    Murakami, Takayuki
    Kishida, Takeshi
    Miura, Takeshi
    Kobayashi, Kazuki
    Noguchi, Sumio
    Ikeda, Ichiro
    Ohgo, Yoshiharu
    Inoue, Tomio
    Kubota, Yoshinobu
    Nakaigawa, Noboru
    BMC CANCER, 2012, 12
  • [7] Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
    Catalano, Martina
    De Giorgi, Ugo
    Maruzzo, Marco
    Bimbatti, Davide
    Buti, Sebastiano
    Mazzaschi, Giulia
    Procopio, Giuseppe
    Santoni, Matteo
    Galli, Luca
    Conca, Raffaele
    Doni, Laura
    Antonuzzo, Lorenzo
    Roviello, Giandomenico
    BIOMEDICINES, 2022, 10 (10)
  • [8] PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma
    Mittlmeier, L. M.
    Unterrainer, M.
    Todica, A.
    Cyran, C. C.
    Rodler, S.
    Bartenstein, P.
    Stief, C. G.
    Ilhan, H.
    Staehler, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (09) : 2216 - 2217
  • [9] PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma
    L. M. Mittlmeier
    M. Unterrainer
    A. Todica
    C. C. Cyran
    S. Rodler
    P. Bartenstein
    C. G. Stief
    H. Ilhan
    M. Staehler
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2216 - 2217
  • [10] FDG PET/CT imaging of metastatic renal squamous cell carcinoma
    Aksoy, S. Y.
    Ozdemir, E.
    Kandemir, Z.
    Yildirim, N.
    Turkolmez, S.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2016, 35 (05): : 347 - 348
12345